Nastech [NSTK] -Sm & Lrg Molecule Intranasal drug delivery Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Nastech [NSTK] -Sm & Lrg Molecule Intranasal drug delivery

MRNA 44.07

-6.0%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: nigel bates who wrote (57)	6/8/2006 12:56:29 AM
From: DewDiligence_on_SI	Read Replies (1) of 80

You asked on another board why this “news” did not attract more attention. The answer is that this it is not a normal IND for a new development program; rather, the IND filing is a consequence of the fact that MRK (NSTK’s former PYY partner) filed the IND for PYY the first time around and, despite pulling out of the collaboration with NSTK, MRK did not cede the IND to NSTK. The market regards intranasal PYY as a failed program because MRK said it didn’t work. Regards, Dew

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next